MTDH associates with m6A RNA methylation and predicts cancer response for immune checkpoint treatment

Summary: Immune checkpoint blockade (ICB) persistently provides a prognosis improvement but only in a small fraction of patients with cancer due to immunotherapy resistance induced by the consecutive activated oncogenic pathways, including MAPK, Akt, and WNT pathway partially driven by Metadherin (M...

Full description

Bibliographic Details
Main Authors: Fen Zhang, Huimei Huang, Yuexiang Qin, Changhan Chen, Li She, Juncheng Wang, Donghai Huang, Qinglai Tang, Yong Liu, Gangcai Zhu, Xin Zhang
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004221010701